A PYMNTS Company

US: FTC says NY’s Medicaid redesign may promote anti-competitive behavior

By  |  May 6, 2015

In a letter to the New York State Department of Health (DOH), the Federal Trade Commission cautioned that part of the State’s Medicaid reform program may sanction anticompetitive behavior.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The FTC’s concern stems from the Certificate of Public Advantage regulations, which offer federal antitrust immunity for certain collaborations among providers participating in the Delivery System Reform Incentive Payments program.

    Specifically, the FTC expressed its “strong concern” that COPAs immunize collaborative activities that otherwise may be impermissible under federal antitrust laws, and may “lead to increased health care costs and decreased access to health care services for New York consumers.”

     

    Full content: The Federal Trade Commission

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.